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Figure 1. Kaplan-Meier Curve:
Positive on 2nd Surgery
Introduction:
Non-Melanoma Skin Cancer (NMSC)
•  Most common cancer in U.S.
•  Greater than 2 million cases treated per year
•  Basal Cell Carcinoma (BCC) and Squamous Cell 
Carcinoma (SCC) make up majority
•  SCC has higher potential for metastases 
•  Majority occur in Head & Neck region, cosmetically 
sensitive locations
Purpose:
Management of positive margins after non-melanoma 
skin cancer (NMSC) excision is controversial. Our 
goal was to determine the rate of residual tumor in re-
excised NMSC specimens after previous excision with 
positive margins (true-positive). Further, we sought to 
determine potential factors that could predict a true-
positive margin.
•  IRB-approved retrospective review
•  A total of 2,886 patients were evaluated; 160 patients 
met inclusion criteria
  –  NMSC excision with positive margins by permanent evaluation and 
subsequent re-excision for clearance of tumor. 
•  Variables collected included: 
  –  age, gender, history of previous skin cancer, location of tumor, skin 
cancer type and subtype, maximal length of lesion upon initial 
excision, maximal length of lesion upon re-excision, surface area 
of initial excision and re-excision, depth of initial excision and re-
excision, perineural invasion, lymphovascular invasion, location of 
positive margin (deep vs. peripheral), and time interval between 
first and second excisions.
Results:
•  83 patients (52%) with positive margins on initial excision had no evidence of 
residual cancer upon re-excision. 
•  Most common locations for lesions with positive margins on initial excision 
were on the face. 
•  Gender and age were not associated with a positive re-excision (p>0.05) 
(Table 1).
•  Patients with a previous history of basal cell carcinoma (BCC) were more 
likely to have a true-positive margin (p= 0.03) (Table 1). 
•  Larger re-excisions were more likely to harbor residual cancer (Table 1). 
•  Location of lesion did not predict positive re-excision (Table 2). 
•  A longer time to re-excision was less likely to find residual cancer (Figure 1).
Conclusion:
The absence of residual tumor after re-excision of specimens 
with positive margins is 52%, similar to that report in the 
literature. Patients with BCC and larger re-excisions are more 
likely to have residual cancer upon re-excision. Lesions with 
positive deep and lateral margins or SCC, are recommended 
for re-excision. Lesions that require re-excision and are located 
in cosmetically sensitive areas may best be served by Mohs 
surgery. For smaller lesions, close observation may be more 
practical method of treatment. 
Discussion:
•  Tissue shrinkage after excision
  –  Healthy skin shrinkage occurs more than tumor laden skin 
•  Host defense clears residual cancer
  –  Longer time to re-excision supports this theory 
•  Use of electrocautery at excision site could destroy remaining 
cancer cells




Female 28 (34%) 31 (40%) 0.30
Age 70.5 + 12.9 72.1 + 14.8 0.69
History of Ca: BCC 19 (22.9%) 31 (40.3%) 0.03
History of Ca: SCC 11 (13.3%) 9 (11.7%) 0.56
Cm2 First Excision 1.36 1.3 0.54
Cm2 Re-excision 2.1 3.1 0.01
Depth First Excision 0.48 0.42 0.52
Depth Re-excision 0.5 0.56 0.37




Face 43 (51.8%) 36 (46.8%) 0.52
Extremities 16 (19.3%) 18 (23.4%) 0.53
Trunk 15 (18.1%) 11 (14.3%) 0.52
Scalp 6 (7.2%) 7 (9.1%) 0.67




































Figure 2. Patient Population 
NMSC Subtypes
Mohs Surgery
